News

It’s been tornados, volcanoes, epidemics, and more. Now we have COVID-19; is the coronavirus here to stay?

On Thursday, March 26, the FDA granted authorization for SomrystTM, a prescription-only digital therapeutic for treatment of chronic insomnia in patients aged 22 years or older.

Take our brief survey and become a member of the Psychiatric Times Reader Reactor Panel.

As the COVID-19 pandemic continues to affect the country, SAMHSA and the DEA allow for flexibility in addressing the needs of patients with opioid use disorder.

Across the centuries, March has been an eventful month for the insanity defense on both sides of the Atlantic, and the McNaughten rule remains the prevalent standard to this day.

We thought it may be useful to have a frequent, but temporary (hopefully very temporary), series of brief pieces on the psychological aspects of the news, along with the occasional longer reflection pieces and podcasts.

The authors discuss abusive disciplinary practices that continue to this day despite considerable evidence to the contrary and share thoughts and implications for psychiatrists.

The COVID-19 pandemic has gained its place on the dark side of world history for a variety of reasons: sudden onset, speed of global transmission, mistakes in recognition and management, politically inspired neglect or minimizations.

I read Dear Provider in a letter from a health care company. Provider is a fine word, and I’ve always felt proud to provide for my family-but the company doesn’t know guys from Jersey are sensitive.

How can psychiatrists advise patients to manage their stress and to remain calm?

In 2009 I attended the United Nations Copenhagen Climate Conference. The general thought at the time was that it was the last best opportunity to keep the world from warming over 2 degrees centigrade.

How much progress has been made in the area of substance use disorders in the last 40 years?

Not that long ago I read a news story about three women who had reported that the psychiatrist treating them had insisted on sex.

College students are uniquely vulnerable to both everyday stressors and severe mental illness, and psychiatric symptoms among college students appear to be on the rise.

What can psychiatrists do to help their patients cope with self-quarantine and isolation practices? More in this podcast.

BPSD is associated with worse outcomes for patients with dementia. Management is not standardized, but protocols generally involve the treatment of underlying symptoms followed by the use of nonpharmacological management techniques and evidence-based pharmacotherapy for refractory BPSD.

What do we tell patients regarding the pandemic both in terms of office policies and preparations for self-isolation and quarantine as well as dealing with uncertainty?

These are hard times, but they get a little easier when we make the decision to unite and go through them together.

Psychiatrists are exploring ways to best serve their patients while complying with the medicolegal restrictions of the coronavirus. Here: approaches to best leverage telemedicine for patients with ADHD.

It is the final phase of God’s work of Creation. It’s a wonderful plan but with an inherent and dreadful problem.

Patient nonadherence to long-term antipsychotic therapy presents clinicians with unique unmet needs but also opportunities for promoting the realistic benefits of consistent treatment.

Many of us are now managing outpatients via phone and telecommunication. While the transition has been relatively painless, one can't help but wonder what the future will bring.

You would think that psychiatrists are well-versed in religion and spirituality, but the reality is that they are barely touched upon during our training.

It can be disheartening to hear about the pervasive culture at many medical centers and health care systems to ostracize the pharmaceutical industry, and not uncommonly, to threaten to fire employed physicians and clinicians who would like to attend educational programs about new medications on their own free time.

An introduction to the March issue.

Experts discuss the rationale and history of L-methylfolate use in patients, and then shares three cases that collectively suggest L-methylfolate may contribute to agitation and mania.

What are the benefits of using LAI antipsychotics? What are the major obstacles to adherence? Those questions and more in this podcast.

Psychiatric Times wants to know how the pandemic is impacting your practice and your lives.